跳至主要内容
临床试验/NCT00439478
NCT00439478已完成不适用

The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 202 人开始时间: 2004年9月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
202
试验地点
1

研究概览

简要总结

We aim to assess the incidence of oral and dental adverse events after high-dose radioiodine therapy for differentiated thyroid cancer.

详细描述

Sialadenitis and xerostomia are the most frequent adverse events of high-dose radioiodine therapy. Saliva has vital functions in maintaining periodontal and oral health. Therefore, xerostomia not only impairs quality of life permanently, but may also increase the risk of caries and tooth extractions. Nevertheless, despite more than 6 decades of radioiodine therapy for thyroid cancer, large studies on long-term oral adverse events are still lacking. In the present study, we investigate the influence of high-dose radioiodine therapy on the long-term oral health.

研究设计

研究类型
Observational

入排标准

性别
All
接受健康志愿者

入选标准

  • histologically confirmed differentiated thyroid cancer
  • status after total thyroidectomy
  • status after subsequent high-dose radioiodine treatment
  • regular follow-up by a board-certified dentist
  • a minimum follow-up of 1 year after radioiodine therapy.

排除标准

  • anaplastic thyroid cancer

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other

研究点 (1)

Loading locations...

相似试验